High Enroll
PrivateLast Round
Seed
Nov 15, 2022
Total Funding Raised
$2.63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
High Enroll operates in Healthcare & Life Sciences and is based in Cincinnati, Ohio. Its latest recorded funding round was a Seed round in November 2022.
High Enroll is a biotechnology company that provides a digital platform to streamline clinical trial participant recruitment for healthcare providers and research institutions.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Workflow Automation
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
High Enroll Comparables
Compare High Enroll with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnrollNow | 83% | |
| Trially AI | 78% | |
| uMotif | 77% |
For institutional investors. Book with your work email.
High Enroll Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 15, 2022 | ||||
| Seed | Aug 4, 2022 | ||||
| Pre Seed | Jul 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 35% MoM.
- Jul 25, 2026
Monthly visitors grew 179% MoM, from 348 to 970.
For institutional investors. Book with your work email.
High Enroll Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about High Enroll's valuation, stock price, and market status.
Is High Enroll a public or private company?
High Enroll is a private company.
What is the current stock price of High Enroll?
High Enroll is a private company, so its shares have no public market price. Caplight tracks High Enroll's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is High Enroll worth (valuation)?
Valuation information for High Enroll is not publicly available.
Can I buy High Enroll stock?
High Enroll shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was High Enroll's last funding round?
High Enroll's most recent funding round was Seed on November 15, 2022.
Who are the main investors in High Enroll?
Investor information for High Enroll is not publicly disclosed.
Will High Enroll IPO soon?
No public IPO plans have been announced for High Enroll.
How can I track High Enroll secondary market activity?
Caplight tracks bids, offers, and trades in High Enroll's shares on secondary markets.